₹ 422.01 Cr
2.39%
BSE Healthcare TRI
INF966L01CH1
5000.0
1000.0
1000
Mr. Sandeep Tandon
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Quant Healthcare Fund - IDCW Option - Regular Plan | 0.43 | - | - |
Benchmark | - | - | - |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Company | Holdings (%) |
---|---|
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.99 |
ASTER DM HEALTHCARE LIMITED EQ | 9.88 |
TREPS 01-Jul-2025 DEPO 10 | 9.72 |
RPG LIFE SCIENCES LIMITED EQ | 8.78 |
SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 6.69 |
PFIZER LIMITED EQ | 6.44 |
ZYDUS WELLNESS LIMITED EQ | 6.11 |
Lupin Limited 31/07/2025 | 6.0 |
HDFC LIFE INSURANCE COMPANY LIMITED EQ | 5.97 |
GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 5.82 |
Sector | Holdings (%) |
---|---|
Healthcare | 68.48 |
Fast Moving Consumer Goods | 6.11 |
Financial Services | 5.97 |
Telecommunication | 4.86 |